KDR rs6828477: Neovascular AMD Susceptibility
The rs6828477 polymorphism is a single nucleotide variant located within the KDR gene on chromosome 4. It has been evaluated in genetic epidemiology studies for its relationship with vascular eye diseases, demonstrating moderate statistical evidence for reduced susceptibility to neovascular age-related macular degeneration. Understanding this variant provides biological insight into angiogenic signaling pathways in the human retina.
What each genotype means
Standard susceptibility profile
This genotype represents the more common state for this variant in many populations. Research suggests that individuals with this genotype may have a different response profile to anti-VEGF therapies for neovascular age-related macular degeneration compared to those carrying the T allele. Please discuss any treatment plans or medication responses with your ophthalmologist or healthcare provider.
This is a common genotype found in many global populations.
Intermediate response profile
Carrying one copy of the T allele may influence how your body responds to certain anti-VEGF treatments for neovascular age-related macular degeneration. Studies have explored associations between this variant and treatment efficacy, though individual outcomes can vary significantly based on other genetic and environmental factors. Always consult with your clinician regarding your specific medical care and treatment options.
This heterozygous genotype is frequently observed in populations where the T allele is present.
Potential treatment response association
Research indicates that the T allele at this position in the KDR gene is associated with variations in susceptibility to neovascular age-related macular degeneration and may influence the effectiveness of anti-VEGF therapies. While these associations are statistically significant in some studies, they do not guarantee a specific clinical outcome. Please discuss these findings with your eye care specialist to understand how they might relate to your personal health management.
This genotype is less common than the C/C genotype, with the T allele showing a minor allele frequency of approximately 0.20-0.30 in East Asian populations.
Variant Genomic Location and Molecular Context
The single nucleotide polymorphism designated rs6828477 is mapped to human chromosome 4 (4q12) in the genomic region encoding the kinase insert domain receptor (KDR). This variant represents an allelic substitution occurring within an intronic or non-coding regulatory segment of the gene, cataloged across major human variation repositories such as dbSNP. Unlike rare, high-impact coding mutations that disrupt the amino acid sequence of the protein, rs6828477 behaves as a common genetic marker. Because it lies within a non-coding portion of the gene locus, researchers often evaluate rs6828477 to determine whether it alters local transcriptional activity, influences mRNA splicing efficiency, or simply acts in linkage disequilibrium with other functional variants across the 4q12 haplotype block.
Biological Role of the KDR Gene
The KDR gene encodes vascular endothelial growth factor receptor 2 (VEGFR-2), a cell-surface receptor tyrosine kinase that serves as the principal transducer of vascular endothelial growth factor (VEGF) signaling in endothelial cells. Upon binding ligands such as VEGFA, VEGFR-2 undergoes dimerization and autophosphorylation, initiating downstream enzymatic cascades that govern endothelial cell proliferation, migration, survival, and vascular permeability. Because VEGFR-2 is central to physiological and pathological angiogenesis, subtle variations in its expression or signaling intensity can modulate blood vessel growth. In ophthalmic pathology, excessive or abnormal VEGF/VEGFR-2 signaling promotes choroidal neovascularization, leading to fragile, leaky capillaries that breach retinal layers.
Association with Neovascular AMD
Neovascular, or 'wet', age-related macular degeneration (nAMD) is a progressive ocular condition characterized by the abnormal proliferation of blood vessels underneath the retina, often causing rapid visual distortion and loss. Genetic association studies evaluating the angiogenic axis have identified rs6828477 as a locus of interest, linking its minor allele with a statistically significant, moderate reduction in susceptibility to nAMD. Rather than eliminating disease risk entirely, carrying the protective allele is thought to attenuate baseline angiogenic reactivity or alter receptor expression dynamics. Although candidate-gene investigations report moderate evidence of this protective correlation, modern multi-ancestry genome-wide association studies show that major risk loci, such as CFH and ARMS2/HTRA1, exert much larger overarching effects on macular degeneration risk.
Population Distribution and Ancestry Patterns
The frequency of rs6828477 varies markedly between geographic ancestries, illustrating the population-specific nature of common genetic variation. Modern population genetic databases and published ophthalmology cohorts show that the minor allele reaches a moderate frequency of approximately 20% to 30% in East Asian populations. In contrast, its prevalence is notably lower among individuals of European, African, and South Asian ancestries. Because the allele frequency differs so widely around the world, the protective statistical association observed in East Asian cohorts may not translate equally across other ethnic backgrounds, underscoring the importance of population-matched genomic research when assessing complex trait architecture.
Clinical Interpretation and Limitations
Direct-to-consumer genetic testing often flags variants like rs6828477, but this information cannot be used to diagnose, prevent, or predict retinal diseases in isolation. The presence of a protective allele represents only a statistical odds ratio calculated in large research cohorts; it does not confer immunity against macular degeneration or substitute for clinical ophthalmic evaluations. Age-related macular degeneration is a complex, multifactorial disease heavily influenced by age, diet, cardiovascular health, and environmental factors like smoking. Furthermore, while VEGF inhibitors form the backbone of clinical nAMD therapy, rs6828477 is not an established pharmacogenetic biomarker for determining drug dosing or clinical treatment choice.
How common is this variant?
The minor allele of rs6828477 occurs at a frequency of approximately 0.20 to 0.30 in East Asian populations, while remaining significantly less common in other ancestral groups such as Europeans and Africans.
Frequently asked questions
Does having the rs6828477 protective allele mean I cannot get macular degeneration?
No, carrying a protective variant does not make someone immune to macular degeneration. Age-related macular degeneration is influenced by multiple genes, age, smoking status, and overall lifestyle. The rs6828477 variant merely confers a moderate statistical reduction in relative susceptibility within studied populations.
What is the primary function of the KDR gene in the body?
KDR encodes VEGFR-2, a major receptor for vascular endothelial growth factor (VEGF). This receptor plays an essential role in regulating new blood vessel growth (angiogenesis), endothelial cell survival, and vascular permeability throughout the body, including the eyes.
Will my rs6828477 genotype influence how I respond to anti-VEGF eye injections?
Current clinical guidelines do not use rs6828477 to determine anti-VEGF treatment plans, dosing, or medication selection. Pharmacogenetic response to retinal therapies is complex, and any questions regarding medication efficacy or treatment should always be discussed directly with an ophthalmologist.
Why is this variant more common in East Asian populations?
Differences in allele frequencies across global populations naturally emerge over generations due to genetic drift, ancestral geographic separation, and historical population bottlenecks. As a result, rs6828477 is observed at a frequency of roughly 20% to 30% in East Asian groups, while being much rarer in European or African ancestries.
Sources & further reading
Educational information only, last refreshed 9/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs6828477?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29